Prognosis of pregnancies after previous complete uterine rupture favorable- Study

Written By :  Dr Nirali Kapoor
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2023-02-24 04:45 GMT   |   Update On 2023-02-24 08:27 GMT

The rate of uterine rupture is increasing worldwide in relation to increased use of caesarean section (CS). As a result, an increasing number of women who have experienced a complete uterine rupture are asking for advice regarding a new pregnancy. Complete uterine rupture, which is often catastrophic, involves all uterine wall layers, including the serosa and membranes. Much more common is the uneventful partial rupture (dehiscence), which spares the serosa or membranes.

Advertisement

Current guidelines from the American College of Obstetricians and Gynecologists (ACOG) recommend that elective repeat CS should be scheduled between 36 and 38/6/7 weeks of gestation for pregnant women with a history of uterine rupture, with eventual changes based on individual evaluation (ACOG 2017). The aim of the present study by Iqbal Al-Zirqi and Siri Vangen was to determine the rate of repeat complete rupture in new pregnancies and the outcomes of such pregnancies. Describing the outcome of these pregnancies may contribute to the individual evaluation of each woman regarding advice on a new pregnancy, followup, and timing of delivery.

They measured the rate of new complete ruptures and partial ruptures, as well as the maternal and perinatal outcomes of these pregnancies. The characteristics of both previous ruptures and new ruptures were described.

Among 72 maternities, there were thirty-seven with previous ruptures in the lower segment (LS) and 35 outside the LS. Authors found three new complete ruptures and six uneventful partial ruptures, resulting in a rate of 4.2% and 8.3%, respectively. All three complete ruptures occurred preterm in scars outside the LS. The rate of the new complete rupture was 0% in those with previous ruptures in the LS and 8.6% in those with previous ruptures outside the LS. The corrected perinatal mortality was 1.3%, and prematurity (<37 weeks) was high (36.1%); this was noticed even in the absence of new ruptures and was mostly iatrogenic. Two hysterectomies were performed in the absence of rupture and two cases had abnormal invasive placenta.><37 weeks) was high (36.1%); this was noticed even in the absence of new ruptures and was mostly iatrogenic. Two hysterectomies were performed in the absence of rupture and two cases had abnormal invasive placenta.

There were three new complete ruptures among 72 mothers with a previous complete uterine rupture (a rate of 4.2%; 8.6% if the previous rupture is outside the LS and 0% if the previous rupture is in the LS). Mothers with repeat complete ruptures presented preterm with acute abdominal pain. There were six partial ruptures that were uneventful except for two premature births at 28 weeks. Te corrected perinatal mortality was 1.3% and prematurity (<37 weeks) was very high (36.1%); this was noted even in the absence of new ruptures and was mostly iatrogenic. Tose with an interdelivery interval of 2–3 years had zero repeat complete ruptures.><37 weeks) was very high (36.1%); this was noted even in the absence of new ruptures and was mostly iatrogenic. Those with an interdelivery interval of 2–3 years had zero repeat complete ruptures.

The prognosis for pregnancies after a previous complete uterine rupture is favorable. Prematurity is mostly iatrogenic, caused by both obstetrician and mother’s anxiety; therefore, the timing of delivery is the most challenging aspect. Careful counseling of the mothers, vigilance for symptoms, and quick access to a tertiary unit are the most important points in management.

Source: Iqbal Al-Zirqi and Siri Vangen ; Hindawi Obstetrics and Gynecology International Volume 2023, Article ID 9056489

https://doi.org/10.1155/2023/9056489


Tags:    
Article Source : Hindawi Obstetrics and Gynecology International

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News